INTERNATIONAL PATENT: BETH ISRAEL DEACONESS MEDICAL CENTER, INC. FILES APPLICATION FOR "THERAPY FOR OCULAR NEOVASCULARIZATION"

GENEVA, Dec. 24 -- BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (330 Brookline AvenueBoston, Massachusetts 02215) filed a patent application (PCT/US2025/033283) for "THERAPY FOR OCULAR NEOVASCULARIZATION" on Jun 12, 2025. With publication no. WO/2025/259836, the details related to the patent application was published on Dec 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FERRAN, Christiane (15 Robbins RoadWatertown, Massachusetts 02472)

Abstract: Provided are molecules and compositions for eye-targeted gene therapy and methods of using the same. The eye-targeted gene therapy alleviates is...